CLOs on the Move


 
Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for people living with kidney disease.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.akebia.com
  • 245 First Street Suite 1400
    Cambridge, MA USA 02142
  • Phone: 617.871.2098

Executives

Name Title Contact Details
Sarah Whipple
VP, Legal and Chief Compliance Officer Profile
Molly Shea
Head of Regulatory Affairs Profile
Henry Gu
Vice President, Chief Intellectual Property Counsel Profile
Andrea Paul
Vice President, Legal - Corporate and Securities Profile
Laura Graham
Director, Corporate Counsel Profile

Similar Companies

Locana

Locana is a RNA-targeting gene therapy company

MultiPlan

MultiPlan is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DEKA BioSciences

Deka BioSciences, Inc. is committed to developing and delivering life-changing medicines to patients with cancer and inflammatory diseases.

Genesis Therapeutics

Genesis Therapeutics is an innovative biotechnology company engaging its proprietary molecular AI technology to transform clinical outcomes for patients. The company was founded in 2019 out of Stanford University by Evan Feinberg Ph.D., co-founded by Ben Sklaroff, and backed by Vijay Pande, Ph.D.

Blue Sky Biotech Inc

Blue Sky Biotech Inc is a Worcester, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.